Prescription ID | TCMF4408 |
Pinyin Name | Mi Niao Ning Ke Li |
Chinese Name | 泌尿宁颗粒 |
English Name | Mi Niao Ning Granules |
Function Description | 热淋 |
Indications | Heat stranguria disorder, Acute prostatitis, Chronic prostatitis, Salmonella pyelonephritis, Chronic pyelonephritis, Cystitis, Urethritis |
Disease ICD-11 Category |
SA91 [Heat stranguria disorder (TM1), 热淋 (TM1)
]; GA91.Y [Other specified inflammatory and other diseases of prostate, 其他特指的前列腺炎性疾病 ]; GA91.0 [Chronic prostatitis, 慢性前列腺炎 ]; GC2Z [Diseases of the urinary system, unspecified, 泌尿系统疾病,未特指的 ]; GB55.Z [Chronic tubulo-interstitial nephritis, unspecified, 慢性肾小管-间质肾炎,未特指的 ]; GC00 [Cystitis, 膀胱炎 ]; GC02.Y [Other specified urethritis and urethral syndrome, 其他特指的尿道炎和尿道综合征 ]; |
Human Tissues Associated with Indication | Bladder |
Reference | CFDA |
Reference Book/link | http://samr.cfda.gov.cn/WS01/CL0001/ |
Component ID | Latin Name | Chinese Name | Component Quantity | Barcode |
---|---|---|---|---|
TCMH228 | Bupleurum chinense | 柴胡 | TCMH228 | ITSAM2218-14 |
TCMH2202 | Schisandra chinensis | 五味子 | TCMH2202 | ITSAM2867-14 |
TCMH177 | Polygonum aviculare | 萹蓄 | TCMH177 | ITSAG3700-14 |
TCMH949 | Phellodendron amurense | 黄柏 | TCMH949 | ITSAM1586-14 |
TCMH118 | Angelica dahurica | 白芷 | TCMH118 | ITSAK3312-14 |
TCMH2334 | Dipsacus japonicus | 续断 | TCMH2334 | ITSAC1509-14 |
TCMH1791 | Loranthus parasiticus | 桑寄生 | TCMH1791 | |
TCMH628 | Glycyrrhiza uralensis | 甘草 | TCMH628 | ITSAM892-14 |
Target ID | Gene Symbol | Target Name | Target Class | Uniprot ID |
---|---|---|---|---|
TCMT100 | TTR | Transthyretin | Unclassified | P02766 |
TCMT101 | PTPN1 | Protein-tyrosine phosphatase 1B | Hydrolase | P18031 |
TCMT112 | ADORA3 | Adenosine A3 receptor | GPCR | P0DMS8 |
TCMT127 | PARP1 | Poly [ADP-ribose] polymerase-1 | Transferase | P09874 |
TCMT128 | TNKS2 | Tankyrase-2 | Transferase | Q9H2K2 |
TCMT129 | TNKS | Tankyrase-1 | Transferase | O95271 |
TCMT13 | APEX1 | DNA-(apurinic or apyrimidinic site) lyase | Lyase | P27695 |
TCMT130 | ALOX5 | Arachidonate 5-lipoxygenase | Oxidoreductase | P09917 |
TCMT131 | ACHE | Acetylcholinesterase | Hydrolase | P22303 |
TCMT133 | CA1 | Carbonic anhydrase I | Lyase | P00915 |
TCMT134 | CA2 | Carbonic anhydrase II | Lyase | P00918 |
TCMT135 | CA14 | Carbonic anhydrase XIV | Lyase | Q9ULX7 |
TCMT136 | CA12 | Carbonic anhydrase XII | Lyase | O43570 |
TCMT137 | CA9 | Carbonic anhydrase IX | Lyase | Q16790 |
TCMT138 | CA7 | Carbonic anhydrase VII | Lyase | P43166 |
TCMT142 | CA4 | Carbonic anhydrase IV | Lyase | P22748 |
TCMT156 | CYP19A1 | Cytochrome P450 19A1 | Oxidoreductase | P11511 |
TCMT159 | TYR | Tyrosinase | Oxidoreductase | P14679 |
TCMT162 | UGT1A1 | UDP-glucuronosyltransferase 1-1 | Transferase | P22309 |
TCMT174 | HSD11B1 | 11-beta-hydroxysteroid dehydrogenase 1 | Oxidoreductase | P28845 |
TCMT190 | PTPN2 | T-cell protein-tyrosine phosphatase | Hydrolase | P17706 |
TCMT2 | MAPT | Microtubule-associated protein tau | Unclassified | P10636 |
TCMT209 | HSD11B2 | 11-beta-hydroxysteroid dehydrogenase 2 | Oxidoreductase | P80365 |
TCMT212 | SRC | Tyrosine-protein kinase SRC | Kinase | P12931 |
TCMT215 | CYP1A1 | Cytochrome P450 1A1 | Oxidoreductase | P04798 |
TCMT217 | CYP2C8 | Cytochrome P450 2C8 | Oxidoreductase | P10632 |
TCMT219 | CYP1A2 | Cytochrome P450 1A2 | Oxidoreductase | P05177 |
TCMT22 | ALPI | Intestinal alkaline phosphatase | Hydrolase | P09923 |
TCMT223 | AKR1B1 | Aldose reductase | Oxidoreductase | P15121 |
TCMT23 | ALPL | Alkaline phosphatase, tissue-nonspecific isozyme | Hydrolase | P05186 |
TCMT231 | GBA2 | Beta-glucosidase | Hydrolase | Q9HCG7 |
TCMT236 | ESR2 | Estrogen receptor beta | Nuclear receptor | Q92731 |
TCMT239 | PIM1 | Serine/threonine-protein kinase PIM1 | Kinase | P11309 |
TCMT240 | AMY1A | Salivary alpha-amylase | Unclassified | P04745 |
TCMT249 | CDK6 | Cyclin-dependent kinase 6 | Kinase | Q00534 |
TCMT257 | CYP1B1 | Cytochrome P450 1B1 | Oxidoreductase | Q16678 |
TCMT260 | FLT3 | Tyrosine-protein kinase receptor FLT3 | Kinase | P36888 |
TCMT261 | DAPK1 | Death-associated protein kinase 1 | Kinase | P53355 |
TCMT27 | DRD1 | Dopamine D1 receptor | GPCR | P21728 |
TCMT280 | AKR1B10 | Aldo-keto reductase family 1 member B10 | Oxidoreductase | O60218 |
TCMT295 | MMP1 | Matrix metalloproteinase-1 | Hydrolase | P03956 |
TCMT296 | ADORA1 | Adenosine A1 receptor | GPCR | P30542 |
TCMT297 | FABP4 | Fatty acid binding protein adipocyte | Unclassified | P15090 |
TCMT298 | FABP3 | Fatty acid binding protein muscle | Hydrolase | P05413 |
TCMT3 | ALOX15 | Arachidonate 15-lipoxygenase | Oxidoreductase | P16050 |
TCMT306 | MMP2 | Matrix metalloproteinase-2 | Hydrolase | P08253 |
TCMT321 | MMP9 | Matrix metalloproteinase 9 | Hydrolase | P14780 |
TCMT322 | MMP13 | Matrix metalloproteinase 13 | Hydrolase | P45452 |
TCMT327 | TRPV1 | Vanilloid receptor | Ion channel | Q8NER1 |
TCMT33 | CYP3A4 | Cytochrome P450 3A4 | Oxidoreductase | P08684 |
TCMT344 | AOX1 | Aldehyde oxidase | Oxidoreductase | Q06278 |
TCMT369 | IGF1R | Insulin-like growth factor I receptor | Kinase | P08069 |
TCMT370 | KDR | Vascular endothelial growth factor receptor 2 | Kinase | P35968 |
TCMT374 | AURKB | Serine/threonine-protein kinase Aurora-B | Kinase | Q96GD4 |
TCMT38 | DRD2 | Dopamine D2 receptor | GPCR | P14416 |
TCMT388 | AXL | Tyrosine-protein kinase receptor UFO | Kinase | P30530 |
TCMT401 | MET | Hepatocyte growth factor receptor | Kinase | P08581 |
TCMT422 | CAMK2B | CaM kinase II beta | Kinase | Q13554 |
TCMT44 | GLO1 | Glyoxalase I | Lyase | Q04760 |
TCMT445 | NEK2 | Serine/threonine-protein kinase NEK2 | Kinase | P51955 |
TCMT46 | F3 | Coagulation factor III | Unclassified | P13726 |
TCMT462 | NEK6 | Serine/threonine-protein kinase NEK6 | Kinase | Q9HC98 |
TCMT47 | BCL2 | Apoptosis regulator Bcl-2 | Ion channel | P10415 |
TCMT479 | AKT1 | Serine/threonine-protein kinase AKT | Kinase | P31749 |
TCMT484 | PLK1 | Serine/threonine-protein kinase PLK1 | Kinase | P53350 |
TCMT506 | PTK2B | Protein tyrosine kinase 2 beta | Kinase | Q14289 |
TCMT558 | TOP2A | DNA topoisomerase II alpha | Isomerase | P11388 |
TCMT560 | F10 | Coagulation factor X | Unclassified | P00742 |
TCMT563 | CDC25B | Dual specificity phosphatase Cdc25B | Hydrolase | P30305 |
TCMT591 | ESRRA | Estrogen-related receptor alpha | Nuclear receptor | P11474 |
TCMT592 | XDH | Xanthine dehydrogenase | Oxidoreductase | P47989 |
TCMT597 | SLC28A3 | Solute carrier family 28 member 3 | Transporter | Q9HAS3 |
TCMT598 | TOP1 | DNA topoisomerase I | Isomerase | P11387 |
TCMT613 | NR3C1 | Glucocorticoid receptor | Nuclear receptor | P04150 |
TCMT614 | EGLN1 | Egl nine homolog 1 | Oxidoreductase | Q9GZT9 |
TCMT63 | PPARA | Peroxisome proliferator-activated receptor alpha | Nuclear receptor | Q07869 |
TCMT65 | HSD17B1 | Estradiol 17-beta-dehydrogenase 1 | Oxidoreductase | P14061 |
TCMT66 | HSD17B2 | Estradiol 17-beta-dehydrogenase 2 | Oxidoreductase | P37059 |
TCMT709 | SLC28A2 | Sodium/nucleoside cotransporter 2 | Transporter | O43868 |
TCMT710 | SLC28A1 | Sodium/nucleoside cotransporter 1 | Transporter | O00337 |
TCMT734 | MMP12 | Matrix metalloproteinase 12 | Hydrolase | P39900 |
TCMT737 | APOBEC3G | DNA dC->dU-editing enzyme APOBEC-3G | Unclassified | Q9HC16 |
TCMT740 | PIK3CG | PI3-kinase p110-gamma subunit | Transferase | P48736 |
TCMT752 | CSNK2A1 | Casein kinase II alpha | Kinase | P68400 |
TCMT771 | ATR | Serine-protein kinase ATR | Kinase | Q13535 |
TCMT784 | AVPR2 | Vasopressin V2 receptor | GPCR | P30518 |
TCMT785 | CXCR1 | Interleukin-8 receptor A | GPCR | P25024 |
TCMT786 | CCR4 | C-C chemokine receptor type 4 | GPCR | P51679 |
TCMT791 | PKN1 | Protein kinase N1 | Kinase | Q16512 |
TCMT793 | PYGL | Liver glycogen phosphorylase | Transferase | P06737 |
TCMT8 | KDM4E | Lysine-specific demethylase 4D-like | Oxidoreductase | B2RXH2 |
TCMT808 | FABP5 | Fatty acid binding protein epidermal | Unclassified | Q01469 |
TCMT809 | FABP2 | Fatty acid binding protein intestinal | Unclassified | P12104 |
TCMT81 | ALOX12 | Arachidonate 12-lipoxygenase | Oxidoreductase | P18054 |
TCMT810 | TLR2 | Toll-like receptor 2 | Unclassified | O60603 |
TCMT82 | ESR1 | Estrogen receptor alpha | Nuclear receptor | P03372 |
TCMT822 | FUT7 | Alpha-(1,3)-fucosyltransferase 7 | Transferase | Q11130 |
TCMT83 | CD38 | Lymphocyte differentiation antigen CD38 | Unclassified | P28907 |
TCMT910 | ESRRB | Estrogen-related receptor beta | Nuclear receptor | O95718 |
Target ID | Target Name |
---|---|
TCMT1170 | Enterobacter cloacae |
TCMT1175 | Human immunodeficiency virus |
TCMT1176 | Streptococcus pneumoniae |
TCMT1178 | Actinomyces viscosus |
TCMT1179 | Escherichia coli ATCC 8739 |
TCMT1180 | Human herpesvirus 2 |
TCMT1181 | Mycobacterium tuberculosis H37Ra |
TCMT1186 | Plasmodium yoelii yoelii |
TCMT1189 | Pseudomonas fluorescens |
TCMT1198 | Serratia marcescens |
TCMT1208 | Escherichia coli K12 |
TCMT1209 | Staphylococcus haemolyticus |
TCMT1210 | Streptococcus sobrinus |
TCMT1211 | Fusobacterium nucleatum |
TCMT1212 | Verticillium dahliae |
TCMT1213 | Neisseria gonorrhoeae |
TCMT1214 | Enterococcus faecium |
TCMT1215 | Pseudomonas aeruginosa PAO1 |
TCMT1218 | Staphylococcus aureus |
TCMT1222 | Plasmodium falciparum D6 |
TCMT1223 | Staphylococcus epidermidis |
TCMT1224 | Proteus mirabilis |
TCMT1226 | Klebsiella pneumoniae |
TCMT1227 | Streptococcus |
TCMT1229 | Enterococcus faecalis |
TCMT1230 | Human herpesvirus 5 |
TCMT1232 | Pseudomonas aeruginosa |
TCMT1234 | Bacillus coagulans |
TCMT1235 | Clostridium sporogenes |
TCMT1236 | Mycobacterium bovis |
TCMT1237 | Mycobacterium kansasii |
TCMT1238 | Mycobacterium xenopi |
TCMT1239 | Mycobacterium marinum |
TCMT1243 | Aspergillus flavus |
TCMT1246 | Escherichia coli |
TCMT1247 | Human herpesvirus 1 |
TCMT1248 | Hepatitis C virus |
TCMT1249 | Dengue virus 2 |
TCMT1250 | Vesicular stomatitis virus |
TCMT1251 | Candida albicans |
TCMT1253 | Penicillium chrysogenum |
TCMT1255 | Human immunodeficiency virus 1 |
TCMT1284 | Penicillium expansum |
TCMT1286 | Bacillus cereus |
TCMT1289 | Shigella dysenteriae |
TCMT1294 | Human parainfluenza virus 3 |
TCMT1305 | Salmonella enteritidis |
TCMT1318 | Human T-lymphotropic virus 1 |
TCMT1321 | Staphylococcus hominis |
TCMT1343 | Staphylococcus simulans |
TCMT1344 | Staphylococcus sciuri |
TCMT1346 | Helicobacter pylori |
TCMT1349 | Helicobacter pylori SS1 |
TCMT1353 | Plasmodium yoelii |
TCMT1361 | Neisseria meningitidis |
TCMT1370 | Prevotella melaninogenica |
TCMT1382 | Plasmodium falciparum (isolate K1 / Thailand) |
TCMT1385 | Candida shehatae |
TCMT1393 | Vibrio sp. |
TCMT1412 | Salmonella typhimurium |
TCMT1438 | Plasmodium falciparum |
TCMT1439 | Mycobacterium smegmatis |
TCMT1442 | Leishmania donovani |
TCMT1443 | Leishmania amazonensis |
TCMT1447 | Respiratory syncytial virus |
TCMT1448 | Enterobacter aerogenes |
TCMT1449 | Influenza A virus |
TCMT1450 | Plasmodium falciparum 3D7 |
TCMT1454 | Bacillus subtilis |
TCMT1455 | Mycobacterium tuberculosis H37Rv |
TCMT1457 | Leishmania major |
TCMT1458 | Filobasidiella neoformans |
TCMT1460 | Mycobacterium intracellulare |
TCMT1462 | Streptococcus mutans |
TCMT1463 | Mycobacterium tuberculosis |
TCMT1464 | Hepatitis B virus |
TCMT1465 | Entamoeba histolytica |
GO Term | GO Name | Enriched Genes | Log10 Adjusted P-value |
---|---|---|---|
[BP] GO:0008152 | metabolic process | ACHE, ADORA1, AKR1B1, AKR1B10, ALOX12, ALOX15, ALOX5, ALPI, ALPL, AOX1, APEX1, AURKB, AXL, BCL2, CA1, CA12, CA2, CA4, CA7, CA9, CDC25B, CDK6, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, DRD1, DRD2, ESR1, ESR2, ESRRA, ESRRB, F10, F3, FABP3, FABP4, FLT3, FUT7, GBA2, GLO1, HSD11B1, HSD11B2, HSD17B1, HSD17B2, IGF1R, KDR, MET, MMP1, MMP12, MMP2, MMP9, NR3C1, PIM1, PPARA, PTPN1, SRC, TNKS, TNKS2, TOP1, TOP2A, TRPV1, TYR, XDH | 12.6391 |
[BP] GO:0006629 | lipid metabolic process | ACHE, ADORA1, AKR1B1, AKR1B10, ALOX12, ALOX15, ALOX5, ALPI, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, DRD2, ESR1, FABP3, FABP4, FUT7, GBA2, HSD11B1, HSD11B2, HSD17B1, HSD17B2, MET, PPARA, TRPV1 | 11.4095 |
[BP] GO:1901700 | response to oxygen-containing compound | AKR1B1, ALPL, APEX1, AXL, BCL2, CA9, CDK6, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, DRD1, DRD2, ESR1, ESRRA, FABP3, HSD11B2, HSD17B2, IGF1R, MMP2, MMP9, NR3C1, PPARA, SRC, TRPV1, TYR | 9.94347 |
[BP] GO:0010033 | response to organic substance | AKR1B1, ALOX15, ALPL, APEX1, AXL, BCL2, CA2, CA9, CDK6, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, DRD1, DRD2, ESR1, ESRRA, FABP3, FABP4, FLT3, HSD11B2, HSD17B2, IGF1R, KDR, MMP2, NR3C1, PPARA, SRC, TRPV1, TYR | 8.91868 |
[BP] GO:0044238 | primary metabolic process | ACHE, ADORA1, AKR1B1, AKR1B10, ALOX12, ALOX15, ALOX5, ALPI, ALPL, AOX1, APEX1, AURKB, AXL, BCL2, CDC25B, CDK6, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, DRD1, DRD2, ESR1, ESR2, ESRRA, ESRRB, F10, F3, FABP3, FABP4, FLT3, FUT7, GBA2, GLO1, HSD11B1, HSD11B2, HSD17B1, HSD17B2, IGF1R, KDR, MET, MMP1, MMP12, MMP2, MMP9, NR3C1, PIM1, PPARA, PTPN1, SRC, TNKS, TNKS2, TOP1, TOP2A, TRPV1, TYR, XDH | 8.89534 |
[BP] GO:0008202 | steroid metabolic process | AKR1B1, AKR1B10, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, ESR1, GBA2, HSD11B1, HSD11B2, HSD17B1, HSD17B2 | 8.37409 |
[BP] GO:0065008 | regulation of biological quality | ACHE, ADORA1, AKR1B1, ALOX12, ALOX15, APEX1, AURKB, AXL, BCL2, CA12, CA2, CA7, CDK6, CYP19A1, CYP1A1, CYP1B1, CYP3A4, DRD1, DRD2, ESR1, F10, F3, FABP3, FABP4, FLT3, HSD11B1, HSD11B2, HSD17B1, HSD17B2, KDR, MET, PPARA, SRC, TNKS, TNKS2, TRPV1, XDH | 8.37409 |
[BP] GO:0014070 | response to organic cyclic compound | ALPL, APEX1, BCL2, CA2, CA9, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, DRD1, DRD2, ESR1, ESRRA, FLT3, HSD11B2, NR3C1, SRC, TRPV1, TYR | 8.32643 |
[BP] GO:0042221 | response to chemical | AKR1B1, ALOX15, ALPL, APEX1, AXL, BCL2, CA2, CA9, CDK6, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, DRD1, DRD2, ESR1, ESRRA, FABP3, FABP4, FLT3, HSD11B2, HSD17B2, IGF1R, KDR, MMP2, MMP9, NR3C1, PPARA, SRC, TOP1, TRPV1, TYR | 8.28788 |
[BP] GO:0071704 | organic substance metabolic process | ACHE, ADORA1, AKR1B1, AKR1B10, ALOX12, ALOX15, ALOX5, ALPI, ALPL, AOX1, APEX1, AURKB, AXL, BCL2, CDC25B, CDK6, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, DRD1, DRD2, ESR1, ESR2, ESRRA, ESRRB, F10, F3, FABP3, FABP4, FLT3, FUT7, GBA2, GLO1, HSD11B1, HSD11B2, HSD17B1, HSD17B2, IGF1R, KDR, MET, MMP1, MMP12, MMP2, MMP9, NR3C1, PIM1, PPARA, PTPN1, SRC, TNKS, TNKS2, TOP1, TOP2A, TRPV1, TYR, XDH | 8.05601 |
[BP] GO:0048522 | positive regulation of cellular process | ACHE, ADORA1, AKR1B1, ALOX12, ALOX15, APEX1, AURKB, AXL, BCL2, CA2, CA7, CDC25B, CDK6, CSNK2A1, CYP19A1, CYP1A1, CYP1B1, DRD1, DRD2, ESR1, ESR2, ESRRA, ESRRB, F10, F3, FABP3, FLT3, IGF1R, KDR, MET, MMP1, MMP12, MMP2, MMP9, NR3C1, PIM1, PPARA, PTPN1, SRC, TNKS, TNKS2, TOP2A, TRPV1, XDH | 7.95186 |
[BP] GO:0044237 | cellular metabolic process | ACHE, AKR1B1, AKR1B10, ALOX12, ALOX15, ALOX5, ALPI, ALPL, AOX1, APEX1, AURKB, AXL, BCL2, CA1, CA12, CA2, CA4, CA7, CA9, CDC25B, CDK6, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, DRD1, DRD2, ESR1, ESR2, ESRRA, ESRRB, F10, FABP3, FABP4, FLT3, FUT7, GBA2, GLO1, HSD17B1, HSD17B2, IGF1R, KDR, MET, MMP1, MMP2, NR3C1, PIM1, PPARA, PTPN1, SRC, TNKS, TNKS2, TOP1, TOP2A, TYR, XDH | 7.93092 |
[BP] GO:0033993 | response to lipid | ALPL, AXL, BCL2, CA2, CA9, CDK6, CSNK2A1, CYP1A1, CYP1A2, ESR1, ESRRA, FABP3, FLT3, HSD11B2, HSD17B2, NR3C1, SRC, TYR | 7.5212 |
[BP] GO:0042445 | hormone metabolic process | ACHE, AKR1B1, CYP19A1, CYP1A1, CYP1B1, CYP3A4, ESR1, HSD11B1, HSD11B2, HSD17B1, HSD17B2 | 7.43384 |
[BP] GO:0009725 | response to hormone | AKR1B1, ALPL, APEX1, BCL2, CA2, CA9, CSNK2A1, CYP1A2, ESR1, ESRRA, FABP3, FLT3, HSD11B2, NR3C1, PPARA, SRC, TRPV1 | 7.20478 |
[BP] GO:0009719 | response to endogenous stimulus | AKR1B1, ALPL, APEX1, BCL2, CA2, CA9, CSNK2A1, CYP1A2, DRD1, ESR1, ESRRA, FABP3, FLT3, HSD11B2, IGF1R, MMP2, NR3C1, PPARA, SRC, TRPV1 | 7.19534 |
[BP] GO:0015701 | bicarbonate transport | CA1, CA12, CA14, CA2, CA4, CA7, CA9 | 6.87948 |
[BP] GO:0044281 | small molecule metabolic process | AKR1B1, AKR1B10, ALOX12, ALOX15, ALOX5, AOX1, CA1, CA12, CA2, CA4, CA7, CA9, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, FABP3, FUT7, GBA2, GLO1, PIM1, PPARA, TYR, XDH | 6.82663 |
[BP] GO:0032501 | multicellular organismal process | ADORA1, AKR1B1, AKR1B10, ALOX12, ALOX15, ALOX5, ALPI, ALPL, AXL, BCL2, CYP19A1, CYP1A2, CYP1B1, DRD1, DRD2, ESR1, ESRRB, F10, F3, FABP4, HSD11B2, HSD17B2, IGF1R, MET, MMP1, MMP12, MMP2, MMP9, PIM1, PPARA, SRC, TNKS2, TOP1, TRPV1, TYR | 6.82324 |
[BP] GO:0048518 | positive regulation of biological process | ACHE, ADORA1, AKR1B1, ALOX12, ALOX15, APEX1, AURKB, AXL, BCL2, CA2, CA7, CDC25B, CDK6, CSNK2A1, CYP19A1, CYP1A1, CYP1B1, DRD1, DRD2, ESR1, ESR2, ESRRA, ESRRB, F10, F3, FABP3, FABP4, FLT3, IGF1R, KDR, MET, MMP1, MMP12, MMP2, MMP9, NR3C1, PIM1, PPARA, PTPN1, SRC, TNKS, TNKS2, TOP2A, TRPV1, XDH | 6.79733 |
[BP] GO:0042493 | response to drug | AKR1B1, APEX1, AXL, BCL2, CA9, CDK6, CYP1A1, CYP1B1, DRD1, DRD2, FABP3, HSD11B2, KDR, NR3C1, SRC, TOP1, TRPV1 | 6.59447 |
[BP] GO:0019748 | secondary metabolic process | AKR1B1, AKR1B10, BCL2, CYP1A1, CYP1A2, CYP1B1, TYR | 6.51478 |
[BP] GO:0010941 | regulation of cell death | ADORA1, AKR1B1, ALOX12, APEX1, AURKB, AXL, BCL2, CSNK2A1, CYP1B1, ESR1, F3, FLT3, GLO1, IGF1R, KDR, MET, MMP9, PIM1, PPARA, PTPN1, SRC, TOP2A, TRPV1, XDH | 6.51126 |
[BP] GO:0010035 | response to inorganic substance | AKR1B1, ALOX15, APEX1, AXL, BCL2, CA2, CYP1A1, CYP1A2, CYP1B1, DRD2, FABP4, KDR, MMP9, SRC | 6.49922 |
[BP] GO:0010647 | positive regulation of cell communication | ADORA1, AKR1B1, ALOX15, AXL, BCL2, CA2, CA7, CSNK2A1, CYP19A1, CYP1B1, DRD1, DRD2, F10, F3, FLT3, KDR, MET, MMP12, MMP9, PTPN1, SRC, TNKS, TNKS2, XDH | 6.49922 |
[BP] GO:0023056 | positive regulation of signaling | ADORA1, AKR1B1, ALOX15, AXL, BCL2, CA2, CA7, CSNK2A1, CYP19A1, CYP1B1, DRD1, DRD2, F10, F3, FLT3, KDR, MET, MMP12, MMP9, PTPN1, SRC, TNKS, TNKS2, XDH | 6.47405 |
[BP] GO:0043067 | regulation of programmed cell death | ADORA1, AKR1B1, ALOX12, APEX1, AURKB, AXL, BCL2, CSNK2A1, CYP1B1, ESR1, F3, FLT3, GLO1, IGF1R, KDR, MET, MMP9, PIM1, PTPN1, SRC, TOP2A, TRPV1, XDH | 6.42839 |
[BP] GO:0055114 | oxidation-reduction process | AKR1B1, AKR1B10, ALOX12, ALOX15, ALOX5, AOX1, APEX1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, HSD11B1, HSD11B2, HSD17B1, HSD17B2, TYR, XDH | 6.2997 |
[BP] GO:0032502 | developmental process | ACHE, ADORA1, AKR1B1, ALOX15, ALPL, APEX1, AURKB, AXL, BCL2, CA2, CA9, CDC25B, CDK6, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DRD1, DRD2, ESR1, ESRRA, ESRRB, FABP4, FLT3, FUT7, GBA2, GLO1, HSD11B1, HSD17B2, KDR, MET, MMP2, MMP9, PIM1, PPARA, SRC, TNKS2, TOP2A, TYR | 6.15359 |
[BP] GO:1901615 | organic hydroxy compound metabolic process | AKR1B1, AKR1B10, ALOX12, ALOX15, BCL2, CYP19A1, CYP1A1, CYP1B1, CYP3A4, DRD1, DRD2, GBA2, TYR | 6.1241 |
[BP] GO:0042446 | hormone biosynthetic process | AKR1B1, CYP19A1, CYP3A4, HSD11B1, HSD11B2, HSD17B1, HSD17B2 | 6.08877 |
[BP] GO:2000145 | regulation of cell motility | ADORA1, ADORA3, ALOX12, APEX1, BCL2, CDK6, CYP19A1, CYP1B1, DRD1, DRD2, F10, F3, IGF1R, KDR, MET, MMP9, SRC | 6.01149 |
[BP] GO:0006730 | one-carbon metabolic process | CA1, CA12, CA2, CA4, CA7, CA9 | 5.9293 |
[BP] GO:0042127 | regulation of cell proliferation | ADORA1, ADORA3, AKR1B1, ALOX12, BCL2, CDC25B, CDK6, CSNK2A1, CYP1B1, DRD2, ESR1, ESRRA, F3, FABP3, FLT3, IGF1R, KDR, MMP12, MMP2, MMP9, PIM1, SRC, XDH | 5.91157 |
[BP] GO:0044255 | cellular lipid metabolic process | ACHE, AKR1B10, ALOX12, ALOX15, ALOX5, ALPI, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, DRD2, FABP3, FABP4, FUT7, GBA2, MET, PPARA | 5.85913 |
[BP] GO:0042981 | regulation of apoptotic process | ADORA1, AKR1B1, ALOX12, APEX1, AURKB, AXL, BCL2, CSNK2A1, CYP1B1, ESR1, F3, FLT3, GLO1, IGF1R, KDR, MMP9, PIM1, PTPN1, SRC, TOP2A, TRPV1, XDH | 5.8321 |
[BP] GO:0034754 | cellular hormone metabolic process | AKR1B1, CYP19A1, CYP1A1, CYP1B1, CYP3A4, ESR1, HSD17B1, HSD17B2 | 5.79941 |
[BP] GO:0030334 | regulation of cell migration | ADORA1, ADORA3, ALOX12, APEX1, BCL2, CYP19A1, CYP1B1, DRD1, DRD2, F10, F3, IGF1R, KDR, MET, MMP9, SRC | 5.57108 |
[BP] GO:0040012 | regulation of locomotion | ADORA1, ADORA3, ALOX12, APEX1, BCL2, CDK6, CYP19A1, CYP1B1, DRD1, DRD2, F10, F3, IGF1R, KDR, MET, MMP9, SRC | 5.5589 |
[BP] GO:0051270 | regulation of cellular component movement | ADORA1, ADORA3, ALOX12, APEX1, BCL2, CDK6, CYP19A1, CYP1B1, DRD1, DRD2, F10, F3, IGF1R, KDR, MET, MMP9, SRC | 5.54549 |
[BP] GO:0032844 | regulation of homeostatic process | ADORA1, AURKB, BCL2, CA2, CA7, CDK6, DRD1, DRD2, KDR, SRC, TNKS, TNKS2, TRPV1 | 5.50622 |
[BP] GO:0050896 | response to stimulus | ACHE, ADORA1, ADORA3, AKR1B1, ALOX15, ALPL, APEX1, AURKB, AXL, BCL2, CA2, CA9, CDK6, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, DRD1, DRD2, ESR1, ESRRA, F10, F3, FABP3, FABP4, FLT3, HSD11B2, HSD17B2, IGF1R, KDR, MMP12, MMP2, MMP9, NR3C1, PPARA, PTPN1, SRC, TOP1, TOP2A, TRPV1, TYR | 5.39503 |
[BP] GO:0070887 | cellular response to chemical stimulus | AKR1B1, ALOX15, ALPL, APEX1, AXL, BCL2, CDK6, CYP1A1, CYP1A2, CYP1B1, DRD1, ESR1, FABP4, FLT3, IGF1R, KDR, MMP2, MMP9, NR3C1, SRC, TRPV1 | 5.24438 |
[BP] GO:0010817 | regulation of hormone levels | ACHE, ADORA1, AKR1B1, CYP19A1, CYP1A1, CYP1B1, CYP3A4, DRD2, ESR1, HSD11B1, HSD11B2, HSD17B1, HSD17B2 | 5.18856 |
[BP] GO:0071310 | cellular response to organic substance | AKR1B1, ALOX15, ALPL, APEX1, AXL, BCL2, CDK6, CYP1A1, CYP1B1, DRD1, ESR1, FABP4, FLT3, IGF1R, KDR, MMP2, NR3C1, SRC, TRPV1 | 5.17287 |
[BP] GO:1901564 | organonitrogen compound metabolic process | ACHE, AKR1B1, ALPI, ALPL, AOX1, AURKB, AXL, BCL2, CDC25B, CDK6, CSNK2A1, CYP1A1, CYP1A2, CYP3A4, DRD1, DRD2, ESR1, F10, F3, FLT3, FUT7, GBA2, GLO1, IGF1R, KDR, MET, MMP1, MMP12, MMP2, MMP9, PIM1, PPARA, PTPN1, SRC, TNKS, TNKS2, TOP1, TOP2A, TYR, XDH | 4.88385 |
[BP] GO:0048523 | negative regulation of cellular process | ACHE, ADORA1, ADORA3, AKR1B1, ALOX12, APEX1, AURKB, AXL, BCL2, CDK6, CSNK2A1, CYP19A1, CYP1B1, DRD1, DRD2, ESR1, ESR2, ESRRA, ESRRB, FABP3, FABP4, GLO1, IGF1R, KDR, MET, MMP12, MMP9, NR3C1, PIM1, PPARA, PTPN1, SRC, TNKS, TNKS2, TOP2A, TRPV1, XDH | 4.87494 |
[BP] GO:2000021 | regulation of ion homeostasis | ADORA1, BCL2, CA2, CA7, DRD1, DRD2, KDR, SRC, TRPV1 | 4.87107 |
[BP] GO:0008284 | positive regulation of cell proliferation | AKR1B1, ALOX12, BCL2, CDC25B, CDK6, CSNK2A1, DRD2, ESR1, F3, FLT3, IGF1R, KDR, MMP12, MMP2, MMP9, PIM1 | 4.86018 |
[BP] GO:0035690 | cellular response to drug | AKR1B1, APEX1, AXL, CDK6, CYP1B1, DRD1, KDR, NR3C1, SRC, TRPV1 | 4.8444 |
[BP] GO:0008610 | lipid biosynthetic process | ACHE, AKR1B1, ALOX12, ALOX15, ALPI, CSNK2A1, CYP19A1, CYP1A1, CYP3A4, HSD11B1, HSD11B2, HSD17B1, HSD17B2 | 4.83366 |
[BP] GO:0032879 | regulation of localization | ACHE, ADORA1, ADORA3, ALOX12, ALOX15, APEX1, AXL, BCL2, CA2, CA7, CDK6, CSNK2A1, CYP19A1, CYP1B1, DRD1, DRD2, F10, F3, IGF1R, KDR, MET, MMP12, MMP9, PPARA, PTPN1, SRC, TRPV1 | 4.71657 |
[BP] GO:0048513 | animal organ development | ACHE, AXL, BCL2, CA2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, ESR1, ESRRA, ESRRB, FLT3, HSD11B1, HSD17B2, KDR, PPARA, SRC, TYR | 4.64394 |
[BP] GO:0006796 | phosphate-containing compound metabolic process | ACHE, ALOX15, ALPI, ALPL, APEX1, AURKB, AXL, BCL2, CDC25B, CDK6, CSNK2A1, DRD1, DRD2, FLT3, IGF1R, KDR, MET, PIM1, PTPN1, SRC, TNKS, TOP1, XDH | 4.61518 |
[BP] GO:0009967 | positive regulation of signal transduction | ADORA1, AKR1B1, ALOX15, AXL, BCL2, CSNK2A1, CYP1B1, DRD2, F10, F3, FLT3, KDR, MET, MMP12, MMP9, PTPN1, SRC, TNKS, TNKS2, XDH | 4.47408 |
[BP] GO:0060548 | negative regulation of cell death | ADORA1, AKR1B1, ALOX12, AURKB, AXL, BCL2, CSNK2A1, GLO1, IGF1R, KDR, MET, MMP9, PIM1, PPARA, PTPN1, SRC | 4.47408 |
[BP] GO:0009636 | response to toxic substance | AKR1B1, ALPL, APEX1, AXL, BCL2, CYP1A1, CYP1B1, DRD1, DRD2, KDR, SRC | 4.44586 |
[BP] GO:0051173 | positive regulation of nitrogen compound metabolic process | ADORA1, ALOX15, AURKB, BCL2, CDC25B, CSNK2A1, DRD1, DRD2, ESR1, ESR2, ESRRA, ESRRB, F3, FLT3, IGF1R, KDR, MET, MMP12, MMP9, NR3C1, PPARA, PTPN1, SRC, TNKS, TNKS2, TOP2A, TRPV1, XDH | 4.3909 |
[BP] GO:0048519 | negative regulation of biological process | ACHE, ADORA1, ADORA3, AKR1B1, ALOX12, ALOX15, APEX1, AURKB, AXL, BCL2, CDK6, CSNK2A1, CYP19A1, CYP1B1, DRD1, DRD2, ESR1, ESR2, ESRRA, ESRRB, FABP3, FABP4, GLO1, IGF1R, KDR, MET, MMP12, MMP9, NR3C1, PIM1, PPARA, PTPN1, SRC, TNKS, TNKS2, TOP2A, TRPV1, XDH | 4.38572 |
[BP] GO:0032847 | regulation of cellular pH reduction | BCL2, CA2, CA7 | 4.36109 |
[BP] GO:0030522 | intracellular receptor signaling pathway | ESR1, ESR2, ESRRA, ESRRB, NR3C1, PIM1, PPARA, SRC | 4.36109 |
[BP] GO:0048871 | multicellular organismal homeostasis | ADORA1, AKR1B1, ALOX12, DRD1, DRD2, MET, TRPV1 | 4.33897 |
[BP] GO:0015711 | organic anion transport | CA1, CA12, CA14, CA2, CA4, CA7, CA9, DRD2, FABP3, PPARA, TRPV1 | 4.3088 |
[BP] GO:0006793 | phosphorus metabolic process | ACHE, ALOX15, ALPI, ALPL, APEX1, AURKB, AXL, BCL2, CDC25B, CDK6, CSNK2A1, DRD1, DRD2, FLT3, IGF1R, KDR, MET, PIM1, PTPN1, SRC, TNKS, TOP1, XDH | 4.30708 |
[BP] GO:0043069 | negative regulation of programmed cell death | ADORA1, AKR1B1, ALOX12, AURKB, AXL, BCL2, CSNK2A1, GLO1, IGF1R, KDR, MET, MMP9, PIM1, PTPN1, SRC | 4.24195 |
[BP] GO:0051716 | cellular response to stimulus | AKR1B1, ALOX15, ALPL, APEX1, AURKB, AXL, BCL2, CA2, CA9, CDK6, CYP1A1, CYP1A2, CYP1B1, DRD1, ESR1, FABP4, FLT3, IGF1R, KDR, MMP2, MMP9, NR3C1, PTPN1, SRC, TOP2A, TRPV1 | 4.17495 |
[BP] GO:0048856 | anatomical structure development | ACHE, ADORA1, AKR1B1, ALOX15, ALPL, AXL, BCL2, CA2, CDK6, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DRD1, DRD2, ESR1, ESRRA, ESRRB, FLT3, GBA2, HSD11B1, HSD17B2, KDR, MMP9, PIM1, PPARA, SRC, TYR | 4.17495 |
[BP] GO:0006694 | steroid biosynthetic process | AKR1B1, CYP19A1, CYP3A4, HSD11B1, HSD11B2, HSD17B1, HSD17B2 | 4.17495 |
[BP] GO:0031325 | positive regulation of cellular metabolic process | ADORA1, ALOX15, AURKB, BCL2, CDC25B, DRD1, DRD2, ESR1, ESR2, ESRRA, ESRRB, F3, FABP3, FLT3, IGF1R, KDR, MET, MMP12, MMP9, NR3C1, PPARA, PTPN1, SRC, TNKS, TNKS2, TOP2A, TRPV1, XDH | 4.10192 |
[BP] GO:0043401 | steroid hormone mediated signaling pathway | ESR1, ESR2, ESRRA, ESRRB, NR3C1, PPARA, SRC | 4.09224 |
[BP] GO:0071407 | cellular response to organic cyclic compound | ALPL, APEX1, CYP1A1, CYP1B1, DRD1, ESR1, FLT3, NR3C1, SRC, TRPV1 | 4.08276 |
[BP] GO:0016042 | lipid catabolic process | ADORA1, AKR1B10, CYP19A1, CYP1A2, CYP1B1, CYP3A4, FABP3, FABP4, GBA2 | 4.04638 |
[BP] GO:0009893 | positive regulation of metabolic process | ADORA1, ALOX15, AURKB, BCL2, CDC25B, CSNK2A1, DRD1, DRD2, ESR1, ESR2, ESRRA, ESRRB, F3, FABP3, FLT3, IGF1R, KDR, MET, MMP12, MMP9, NR3C1, PPARA, PTPN1, SRC, TNKS, TNKS2, TOP2A, TRPV1, XDH | 3.988 |
[BP] GO:0048584 | positive regulation of response to stimulus | ADORA1, AKR1B1, ALOX15, AXL, BCL2, CSNK2A1, CYP1B1, DRD2, ESRRA, F10, F3, FABP4, FLT3, KDR, MET, MMP12, MMP2, MMP9, PTPN1, SRC, TNKS, TNKS2, XDH | 3.90663 |
[BP] GO:0009056 | catabolic process | ACHE, ADORA1, AKR1B10, AOX1, AURKB, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, FABP3, FABP4, FUT7, GBA2, MMP1, MMP12, MMP2, MMP9, SRC, XDH | 3.9023 |
[BP] GO:0042592 | homeostatic process | ADORA1, AKR1B1, ALOX12, APEX1, AXL, BCL2, CA12, CA2, CA7, DRD1, DRD2, ESR1, FABP3, FABP4, FLT3, MET, SRC, TRPV1 | 3.89258 |
[BP] GO:0048511 | rhythmic process | AXL, BCL2, CSNK2A1, DRD2, ESR1, PPARA, SRC, TOP1, TOP2A | 3.89258 |
[BP] GO:0006468 | protein phosphorylation | AURKB, AXL, BCL2, CDC25B, CDK6, CSNK2A1, DRD1, FLT3, IGF1R, KDR, MET, PIM1, SRC, TNKS, TOP1 | 3.89258 |
[BP] GO:0032845 | None | ADORA1, BCL2, DRD2, SRC, TNKS, TNKS2, TRPV1 | 3.83706 |
[BP] GO:0010646 | regulation of cell communication | ACHE, ADORA1, AKR1B1, ALOX15, AURKB, AXL, BCL2, CA2, CA7, CSNK2A1, CYP19A1, CYP1B1, DRD1, DRD2, ESR1, ESR2, F10, F3, FLT3, IGF1R, KDR, MET, MMP12, MMP9, PTPN1, SRC, TNKS, TNKS2, XDH | 3.78563 |
[BP] GO:2001300 | lipoxin metabolic process | ALOX12, ALOX15, ALOX5 | 3.77624 |
[BP] GO:1902533 | positive regulation of intracellular signal transduction | ADORA1, AKR1B1, ALOX15, AXL, BCL2, CYP1B1, DRD2, F10, F3, FLT3, KDR, MET, PTPN1, SRC, XDH | 3.69429 |
[BP] GO:0023051 | regulation of signaling | ACHE, ADORA1, AKR1B1, ALOX15, AURKB, AXL, BCL2, CA2, CA7, CSNK2A1, CYP19A1, CYP1B1, DRD1, DRD2, ESR1, ESR2, F10, F3, FLT3, IGF1R, KDR, MET, MMP12, MMP9, PTPN1, SRC, TNKS, TNKS2, XDH | 3.69028 |
[BP] GO:0033559 | unsaturated fatty acid metabolic process | ALOX12, ALOX15, ALOX5, CYP1A1, CYP1A2, CYP1B1 | 3.66241 |
[BP] GO:0043066 | negative regulation of apoptotic process | ADORA1, AKR1B1, ALOX12, AURKB, AXL, BCL2, CSNK2A1, GLO1, IGF1R, KDR, MMP9, PIM1, PTPN1, SRC | 3.64416 |
[BP] GO:0048583 | regulation of response to stimulus | ADORA1, AKR1B1, ALOX12, ALOX15, AURKB, AXL, BCL2, CDK6, CSNK2A1, CYP19A1, CYP1B1, DRD1, DRD2, ESR1, ESR2, ESRRA, F10, F3, FABP4, FLT3, IGF1R, KDR, MET, MMP12, MMP2, MMP9, PPARA, PTPN1, SRC, TNKS, TNKS2, XDH | 3.64233 |
[BP] GO:0019369 | arachidonic acid metabolic process | ALOX12, ALOX15, CYP1A1, CYP1A2, CYP1B1 | 3.62568 |
[BP] GO:0008210 | estrogen metabolic process | CYP19A1, CYP1B1, HSD17B1, HSD17B2 | 3.5825 |
[BP] GO:0010604 | positive regulation of macromolecule metabolic process | ADORA1, ALOX15, AURKB, BCL2, CDC25B, CSNK2A1, DRD1, DRD2, ESR1, ESR2, ESRRA, ESRRB, F3, FLT3, IGF1R, KDR, MET, MMP12, MMP9, NR3C1, PPARA, PTPN1, SRC, TNKS, TNKS2, TOP2A, XDH | 3.57722 |
[BP] GO:0018193 | peptidyl-amino acid modification | AURKB, AXL, BCL2, CSNK2A1, DRD1, F10, FLT3, IGF1R, KDR, MET, SRC, TNKS, TOP1, TOP2A | 3.52799 |
[BP] GO:0006690 | icosanoid metabolic process | ALOX12, ALOX15, ALOX5, CYP1A1, CYP1A2, CYP1B1 | 3.51414 |
[BP] GO:1901701 | cellular response to oxygen-containing compound | AKR1B1, APEX1, AXL, CDK6, CYP1B1, DRD1, ESR1, IGF1R, MMP2, MMP9, NR3C1, SRC, TRPV1 | 3.51414 |
[BP] GO:0009755 | hormone-mediated signaling pathway | ESR1, ESR2, ESRRA, ESRRB, NR3C1, PPARA, SRC | 3.47838 |
[BP] GO:0010243 | response to organonitrogen compound | AKR1B1, APEX1, DRD1, DRD2, FABP3, FLT3, HSD11B2, IGF1R, MMP2, PPARA, SRC, TRPV1, TYR | 3.47838 |
[BP] GO:0042542 | response to hydrogen peroxide | AKR1B1, APEX1, AXL, BCL2, CYP1B1, SRC | 3.43814 |
[BP] GO:0034614 | cellular response to reactive oxygen species | AKR1B1, APEX1, AXL, CYP1B1, MMP9, SRC | 3.43814 |
[BP] GO:0048585 | negative regulation of response to stimulus | ADORA1, ALOX12, ALOX15, BCL2, CDK6, CYP19A1, DRD1, DRD2, ESR1, ESR2, IGF1R, MET, MMP12, MMP9, PPARA, PTPN1, SRC, XDH | 3.43224 |
[BP] GO:1902531 | regulation of intracellular signal transduction | ADORA1, AKR1B1, ALOX15, AURKB, AXL, BCL2, CSNK2A1, CYP1B1, DRD2, ESR1, F10, F3, FLT3, IGF1R, KDR, MET, MMP9, PTPN1, SRC, XDH | 3.42575 |
[BP] GO:0000302 | response to reactive oxygen species | AKR1B1, APEX1, AXL, BCL2, CYP1B1, MMP9, SRC | 3.38379 |
[BP] GO:0006820 | anion transport | CA1, CA12, CA14, CA2, CA4, CA7, CA9, DRD2, FABP3, PPARA, TRPV1 | 3.36316 |
[BP] GO:0030335 | positive regulation of cell migration | ALOX12, BCL2, DRD1, F10, F3, IGF1R, KDR, MET, MMP9, SRC | 3.32668 |
[BP] GO:0009611 | response to wounding | ACHE, ADORA3, ALOX15, BCL2, CYP1A1, DRD2, PPARA | 3.31586 |
[BP] GO:0001666 | response to hypoxia | ADORA1, BCL2, CYP1A1, DRD2, HSD11B2, MMP2, PPARA, SRC | 3.2862 |
[BP] GO:2000147 | positive regulation of cell motility | ALOX12, BCL2, DRD1, F10, F3, IGF1R, KDR, MET, MMP9, SRC | 3.21284 |
[BP] GO:0036293 | response to decreased oxygen levels | ADORA1, BCL2, CYP1A1, DRD2, HSD11B2, MMP2, PPARA, SRC | 3.20719 |
[BP] GO:0001659 | None | ADORA1, DRD1, DRD2, TRPV1 | 3.20719 |
[BP] GO:1901698 | response to nitrogen compound | AKR1B1, APEX1, DRD1, DRD2, FABP3, FLT3, HSD11B2, IGF1R, MMP2, PPARA, SRC, TRPV1, TYR | 3.17833 |
[BP] GO:0032228 | regulation of synaptic transmission, GABAergic | ADORA1, CA2, CA7, DRD2 | 3.15667 |
[BP] GO:0097267 | omega-hydroxylase P450 pathway | CYP1A1, CYP1A2, CYP1B1 | 3.13259 |
[BP] GO:0051272 | positive regulation of cellular component movement | ALOX12, BCL2, DRD1, F10, F3, IGF1R, KDR, MET, MMP9, SRC | 3.12445 |
[BP] GO:0046777 | protein autophosphorylation | AURKB, CSNK2A1, FLT3, IGF1R, KDR, PIM1, SRC | 3.09763 |
[BP] GO:0032787 | None | ALOX12, ALOX15, ALOX5, CYP1A1, CYP1A2, CYP1B1, FABP3, GBA2, GLO1, PPARA | 3.06924 |
[BP] GO:0040017 | positive regulation of locomotion | ALOX12, BCL2, DRD1, F10, F3, IGF1R, KDR, MET, MMP9, SRC | 3.01023 |
[BP] GO:0009628 | response to abiotic stimulus | ADORA1, AKR1B1, AURKB, BCL2, CA2, CYP1A1, DRD1, DRD2, HSD11B2, MMP2, PPARA, SRC, TRPV1, TYR | 2.97333 |
[BP] GO:0070482 | response to oxygen levels | ADORA1, BCL2, CYP1A1, DRD2, HSD11B2, MMP2, PPARA, SRC | 2.97333 |
[BP] GO:0018958 | None | AKR1B1, BCL2, DRD1, DRD2, TYR | 2.96444 |
[BP] GO:0016310 | phosphorylation | AURKB, AXL, BCL2, CDC25B, CDK6, CSNK2A1, DRD1, FLT3, IGF1R, KDR, MET, PIM1, SRC, TNKS, TOP1 | 2.96444 |
[BP] GO:0009891 | positive regulation of biosynthetic process | AURKB, DRD1, DRD2, ESR1, ESR2, ESRRA, ESRRB, FABP3, IGF1R, KDR, MET, MMP12, NR3C1, PPARA, SRC, TNKS, TNKS2, TOP2A, TRPV1 | 2.94401 |
[BP] GO:0006631 | fatty acid metabolic process | ALOX12, ALOX15, ALOX5, CYP1A1, CYP1A2, CYP1B1, FABP3, PPARA | 2.93368 |
[BP] GO:0051896 | regulation of protein kinase B signaling | AXL, DRD2, F10, F3, MET, SRC, XDH | 2.9317 |
[BP] GO:0044092 | negative regulation of molecular function | ADORA3, AURKB, CSNK2A1, CYP1B1, DRD2, ESR1, FABP4, IGF1R, MET, MMP9, PIM1, PPARA, PTPN1, SRC, TNKS | 2.91851 |
[BP] GO:0006807 | nitrogen compound metabolic process | ACHE, AKR1B1, AKR1B10, ALPI, ALPL, AOX1, APEX1, AURKB, AXL, BCL2, CDC25B, CDK6, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, DRD1, DRD2, ESR1, ESR2, ESRRA, ESRRB, F10, F3, FLT3, FUT7, GBA2, GLO1, IGF1R, KDR, MET, MMP1, MMP12, MMP2, MMP9, NR3C1, PIM1, PPARA, PTPN1, SRC, TNKS, TNKS2, TOP1, TOP2A, TYR, XDH | 2.84856 |
[BP] GO:0048545 | response to steroid hormone | ALPL, BCL2, CA2, FLT3, HSD11B2, NR3C1, SRC | 2.83469 |
[BP] GO:0006703 | estrogen biosynthetic process | CYP19A1, HSD17B1, HSD17B2 | 2.81975 |
[BP] GO:0009115 | None | AOX1, XDH | 2.81354 |
[BP] GO:2001301 | lipoxin biosynthetic process | ALOX12, ALOX15 | 2.81354 |
[BP] GO:2001302 | lipoxin A4 metabolic process | ALOX12, ALOX15 | 2.81354 |
[BP] GO:2001303 | lipoxin A4 biosynthetic process | ALOX12, ALOX15 | 2.81354 |
[BP] GO:0022414 | reproductive process | AKR1B1, ALPL, AXL, BCL2, CDC25B, CYP19A1, CYP1A1, DRD1, ESR1, ESRRB, HSD11B2, HSD17B2, MMP2, MMP9, SRC, TOP2A | 2.80569 |
[BP] GO:0017144 | drug metabolic process | ACHE, AKR1B1, AKR1B10, AOX1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, DRD1, DRD2 | 2.7776 |
[BP] GO:0032846 | positive regulation of homeostatic process | AURKB, CA2, CA7, DRD1, DRD2, TNKS, TNKS2 | 2.7776 |
[BP] GO:0060065 | uterus development | CYP19A1, ESR1, SRC | 2.75095 |
[BP] GO:0010038 | response to metal ion | ALOX15, BCL2, CA2, CYP1A1, CYP1A2, DRD2, FABP4, MMP9 | 2.75095 |
[BP] GO:0032101 | regulation of response to external stimulus | ADORA1, ALOX12, CYP19A1, DRD1, DRD2, ESR1, F3, FABP4, KDR, MET, MMP12, PPARA | 2.74957 |
[BP] GO:0019222 | regulation of metabolic process | ACHE, ADORA1, ADORA3, ALOX15, APEX1, AURKB, BCL2, CA9, CDC25B, CDK6, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, DRD1, DRD2, ESR1, ESR2, ESRRA, ESRRB, F3, FABP3, FABP4, FLT3, GLO1, IGF1R, KDR, MET, MMP12, MMP9, NR3C1, PIM1, PPARA, PTPN1, SRC, TNKS, TNKS2, TOP1, TOP2A, TRPV1, XDH | 2.74291 |
[BP] GO:0031960 | response to corticosteroid | ALPL, BCL2, FLT3, HSD11B2, NR3C1, SRC | 2.71187 |
[BP] GO:1901568 | fatty acid derivative metabolic process | ALOX12, ALOX15, ALOX5, CYP1A1, CYP1A2, CYP1B1 | 2.71187 |
[BP] GO:0060255 | regulation of macromolecule metabolic process | ACHE, ADORA1, ADORA3, ALOX15, APEX1, AURKB, BCL2, CA9, CDC25B, CDK6, CSNK2A1, CYP1A2, CYP1B1, DRD1, DRD2, ESR1, ESR2, ESRRA, ESRRB, F3, FABP4, FLT3, GLO1, IGF1R, KDR, MET, MMP12, MMP9, NR3C1, PIM1, PPARA, PTPN1, SRC, TNKS, TNKS2, TOP1, TOP2A, TRPV1, XDH | 2.68548 |
[BP] GO:0048878 | chemical homeostasis | AKR1B1, ALOX12, BCL2, CA12, CA2, CA7, DRD1, DRD2, ESR1, FABP3, FABP4, MET, TRPV1 | 2.65276 |
[BP] GO:0006367 | transcription initiation from RNA polymerase II promoter | ESR1, ESR2, ESRRA, ESRRB, NR3C1, PPARA | 2.64289 |
[BP] GO:0003014 | None | ADORA1, AKR1B1, BCL2, DRD2, HSD11B2 | 2.61735 |
[BP] GO:1901617 | organic hydroxy compound biosynthetic process | AKR1B1, ALOX12, ALOX15, CYP19A1, CYP3A4, TYR | 2.61735 |
[BP] GO:0010562 | positive regulation of phosphorus metabolic process | ADORA1, ALOX15, BCL2, CDC25B, DRD1, DRD2, ESRRB, FABP3, FLT3, KDR, MMP9, PTPN1, SRC, XDH | 2.61735 |
[BP] GO:0045937 | positive regulation of phosphate metabolic process | ADORA1, ALOX15, BCL2, CDC25B, DRD1, DRD2, ESRRB, FABP3, FLT3, KDR, MMP9, PTPN1, SRC, XDH | 2.61735 |
[BP] GO:0030540 | female genitalia development | AXL, CYP19A1, ESR1 | 2.60808 |
[BP] GO:0019372 | lipoxygenase pathway | ALOX12, ALOX15, ALOX5 | 2.60808 |
[BP] GO:0018105 | peptidyl-serine phosphorylation | AURKB, BCL2, DRD1, SRC, TNKS, TOP1 | 2.58345 |
[BP] GO:0031328 | positive regulation of cellular biosynthetic process | AURKB, DRD1, DRD2, ESR1, ESR2, ESRRA, ESRRB, FABP3, IGF1R, MET, MMP12, NR3C1, PPARA, SRC, TNKS, TNKS2, TOP2A, TRPV1 | 2.55212 |
[BP] GO:0001676 | long-chain fatty acid metabolic process | ALOX12, ALOX15, CYP1A1, CYP1A2, CYP1B1 | 2.54879 |
[BP] GO:1904355 | positive regulation of telomere capping | AURKB, TNKS, TNKS2 | 2.53606 |
[BP] GO:1901652 | response to peptide | AKR1B1, APEX1, FABP3, HSD11B2, IGF1R, PPARA, SRC, TRPV1 | 2.52481 |
[BP] GO:0072593 | reactive oxygen species metabolic process | ALOX12, BCL2, CYP1A1, CYP1A2, CYP1B1 | 2.51609 |
[BP] GO:0080134 | regulation of response to stress | ADORA1, ALOX12, CDK6, CYP19A1, DRD2, ESR1, F3, FABP4, IGF1R, MET, MMP12, MMP2, PPARA, PTPN1, SRC, XDH | 2.47551 |
[BP] GO:0016137 | None | AKR1B1, AKR1B10, GBA2 | 2.4689 |
[BP] GO:0044236 | multicellular organism metabolic process | MMP1, MMP12, MMP2, MMP9, TRPV1 | 2.44423 |
[BP] GO:0032210 | regulation of telomere maintenance via telomerase | AURKB, SRC, TNKS, TNKS2 | 2.43727 |
[BP] GO:0006721 | terpenoid metabolic process | AKR1B10, CYP1A1, CYP1A2, CYP1B1, CYP3A4 | 2.43499 |
[BP] GO:0046110 | None | AOX1, XDH | 2.43499 |
[BP] GO:0032849 | positive regulation of cellular pH reduction | CA2, CA7 | 2.43499 |
[BP] GO:0019538 | protein metabolic process | ACHE, ALPI, ALPL, AURKB, AXL, BCL2, CDC25B, CDK6, CSNK2A1, DRD1, ESR1, F10, F3, FLT3, FUT7, IGF1R, KDR, MET, MMP1, MMP12, MMP2, MMP9, PIM1, PPARA, PTPN1, SRC, TNKS, TNKS2, TOP1, TOP2A | 2.43499 |
[BP] GO:0019752 | carboxylic acid metabolic process | ALOX12, ALOX15, ALOX5, CYP1A1, CYP1A2, CYP1B1, FABP3, GBA2, GLO1, PIM1, PPARA, TYR | 2.43499 |
[BP] GO:0030336 | None | ADORA1, ADORA3, APEX1, BCL2, CYP19A1, CYP1B1, DRD2 | 2.42821 |
[BP] GO:0051900 | regulation of mitochondrial depolarization | BCL2, KDR, SRC | 2.42256 |
[BP] GO:0097164 | None | ACHE, AKR1B1, AKR1B10, CSNK2A1, DRD1, DRD2 | 2.39528 |
[BP] GO:0051130 | positive regulation of cellular component organization | ALOX15, AURKB, AXL, BCL2, DRD2, ESR1, IGF1R, KDR, MET, MMP1, MMP9, SRC, TNKS, TNKS2 | 2.38286 |
[BP] GO:0018209 | peptidyl-serine modification | AURKB, BCL2, DRD1, SRC, TNKS, TOP1 | 2.37276 |
[BP] GO:0042325 | regulation of phosphorylation | ADORA1, ALOX15, BCL2, CDC25B, DRD1, DRD2, ESRRB, FABP4, FLT3, IGF1R, KDR, MMP9, PPARA, PTPN1, SRC, XDH | 2.36572 |
[BP] GO:0018108 | peptidyl-tyrosine phosphorylation | AXL, FLT3, IGF1R, KDR, MET, SRC | 2.35248 |
[BP] GO:0001503 | ossification | ALOX15, ALPL, BCL2, MMP2, MMP9 | 2.33356 |
[BP] GO:0048869 | cellular developmental process | ACHE, ALPL, AXL, BCL2, CDC25B, CDK6, CYP1A1, DRD1, DRD2, ESR1, ESRRB, FABP4, FLT3, FUT7, GBA2, GLO1, KDR, MET, MMP2, MMP9, SRC, TOP2A | 2.32317 |
[BP] GO:0018212 | peptidyl-tyrosine modification | AXL, FLT3, IGF1R, KDR, MET, SRC | 2.3196 |
[BP] GO:0019373 | epoxygenase P450 pathway | CYP1A1, CYP1A2, CYP1B1 | 2.30896 |
[BP] GO:2000146 | None | ADORA1, ADORA3, APEX1, BCL2, CYP19A1, CYP1B1, DRD2 | 2.30329 |
[BP] GO:0034502 | protein localization to chromosome | AURKB, ESR1, TNKS, TNKS2 | 2.30297 |
[BP] GO:0070988 | demethylation | APEX1, CYP1A1, CYP1A2, CYP3A4 | 2.30297 |
[BP] GO:0007169 | transmembrane receptor protein tyrosine kinase signaling pathway | AXL, FLT3, IGF1R, KDR, MET, MMP2, MMP9, PTPN1, SRC | 2.29048 |
[BP] GO:1904356 | regulation of telomere maintenance via telomere lengthening | AURKB, SRC, TNKS, TNKS2 | 2.27982 |
[BP] GO:0034599 | cellular response to oxidative stress | AKR1B1, APEX1, AXL, CYP1B1, MMP9, SRC | 2.27364 |
[BP] GO:0030520 | intracellular estrogen receptor signaling pathway | ESR1, ESR2, SRC | 2.2634 |
[BP] GO:0070301 | cellular response to hydrogen peroxide | AKR1B1, APEX1, AXL, CYP1B1 | 2.25895 |
[BP] GO:0045935 | positive regulation of nucleobase-containing compound metabolic process | AURKB, DRD1, DRD2, ESR1, ESR2, ESRRA, ESRRB, IGF1R, MET, MMP12, NR3C1, PPARA, PTPN1, SRC, TNKS, TNKS2, TOP2A | 2.25557 |
[BP] GO:0097237 | cellular response to toxic substance | AKR1B1, APEX1, AXL, CYP1B1, KDR | 2.25557 |
[BP] GO:0050806 | positive regulation of synaptic transmission | ADORA1, CA2, CA7, DRD1, DRD2 | 2.24023 |
[BP] GO:0065007 | biological regulation | ACHE, ADORA1, ADORA3, AKR1B1, ALOX12, ALOX15, APEX1, AURKB, AXL, BCL2, CA1, CA12, CA2, CA7, CA9, CDC25B, CDK6, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, DRD1, DRD2, ESR1, ESR2, ESRRA, ESRRB, F10, F3, FABP3, FABP4, FLT3, GLO1, HSD11B1, HSD11B2, HSD17B1, HSD17B2, IGF1R, KDR, MET, MMP1, MMP12, MMP2, MMP9, NR3C1, PIM1, PPARA, PTPN1, SRC, TNKS, TNKS2, TOP1, TOP2A, TRPV1, XDH | 2.2155 |
[BP] GO:0009404 | toxin metabolic process | CYP1A1, CYP1A2, CYP1B1 | 2.21478 |
[BP] GO:0019220 | regulation of phosphate metabolic process | ADORA1, ALOX15, BCL2, CDC25B, DRD1, DRD2, ESRRB, FABP3, FABP4, FLT3, IGF1R, KDR, MMP9, PPARA, PTPN1, SRC, XDH | 2.21432 |
[BP] GO:0009966 | regulation of signal transduction | ADORA1, AKR1B1, ALOX15, AURKB, AXL, BCL2, CSNK2A1, CYP1B1, DRD2, ESR1, ESR2, F10, F3, FLT3, IGF1R, KDR, MET, MMP12, MMP9, PTPN1, SRC, TNKS, TNKS2, XDH | 2.20997 |
[BP] GO:0050878 | regulation of body fluid levels | ADORA1, AKR1B1, ALOX12, DRD2, F10, F3, MET, XDH | 2.20997 |
[BP] GO:1902532 | negative regulation of intracellular signal transduction | BCL2, DRD2, ESR1, IGF1R, MET, MMP9, PTPN1, SRC, XDH | 2.20997 |
[BP] GO:0070213 | None | TNKS, TNKS2 | 2.20997 |
[BP] GO:0006145 | None | AOX1, XDH | 2.20997 |
[BP] GO:0018894 | dibenzo-p-dioxin metabolic process | CYP1A1, CYP1A2 | 2.20997 |
[BP] GO:0050805 | negative regulation of synaptic transmission | ACHE, ADORA1, DRD1, DRD2 | 2.20719 |
[BP] GO:2000573 | positive regulation of DNA biosynthetic process | AURKB, SRC, TNKS, TNKS2 | 2.20719 |
[BP] GO:0051271 | None | ADORA1, ADORA3, APEX1, BCL2, CYP19A1, CYP1B1, DRD2 | 2.20132 |
[BP] GO:0006720 | isoprenoid metabolic process | AKR1B10, CYP1A1, CYP1A2, CYP1B1, CYP3A4 | 2.20132 |
[BP] GO:0051174 | regulation of phosphorus metabolic process | ADORA1, ALOX15, BCL2, CDC25B, DRD1, DRD2, ESRRB, FABP3, FABP4, FLT3, IGF1R, KDR, MMP9, PPARA, PTPN1, SRC, XDH | 2.1954 |
[BP] GO:0046486 | glycerolipid metabolic process | ACHE, ALOX15, ALPI, CSNK2A1, DRD2, FABP3, FABP4, MET | 2.1922 |
[BP] GO:0030574 | collagen catabolic process | MMP1, MMP12, MMP2, MMP9 | 2.19096 |
[BP] GO:1903409 | reactive oxygen species biosynthetic process | CYP1A1, CYP1A2, CYP1B1 | 2.19095 |
[BP] GO:0006352 | DNA-templated transcription, initiation | ESR1, ESR2, ESRRA, ESRRB, NR3C1, PPARA | 2.19029 |
[BP] GO:0043393 | regulation of protein binding | AURKB, BCL2, MET, MMP9, PPARA, SRC | 2.19029 |
[BP] GO:0008283 | cell proliferation | ACHE, AURKB, BCL2, CYP1A1, ESR1, FLT3, MET, PIM1, SRC, TYR | 2.16999 |
[BP] GO:0043436 | oxoacid metabolic process | ALOX12, ALOX15, ALOX5, CYP1A1, CYP1A2, CYP1B1, FABP3, GBA2, GLO1, PIM1, PPARA, TYR | 2.11501 |
[BP] GO:0009892 | negative regulation of metabolic process | ADORA1, APEX1, AURKB, BCL2, CSNK2A1, DRD2, ESR1, ESR2, ESRRA, FABP4, IGF1R, KDR, MET, MMP12, MMP9, NR3C1, PPARA, PTPN1, SRC, TNKS, TNKS2, TRPV1, XDH | 2.10723 |
[BP] GO:0009987 | cellular process | ACHE, ADORA1, ADORA3, AKR1B1, AKR1B10, ALOX12, ALOX15, ALOX5, ALPI, ALPL, AOX1, APEX1, AURKB, AXL, BCL2, CA1, CA12, CA2, CA4, CA7, CA9, CDC25B, CDK6, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, DRD1, DRD2, ESR1, ESR2, ESRRA, ESRRB, F10, F3, FABP3, FABP4, FLT3, FUT7, GBA2, GLO1, HSD17B1, HSD17B2, IGF1R, KDR, MET, MMP1, MMP12, MMP2, MMP9, NR3C1, PIM1, PPARA, PTPN1, SRC, TNKS, TNKS2, TOP1, TOP2A, TRPV1, TYR, XDH | 2.10561 |
[BP] GO:0042180 | None | AKR1B1, AKR1B10, CYP19A1, GLO1 | 2.10561 |
[BP] GO:0007166 | cell surface receptor signaling pathway | ADORA1, ADORA3, AXL, BCL2, CA1, CSNK2A1, DRD2, F3, FLT3, IGF1R, KDR, MET, MMP2, MMP9, PTPN1, SRC, TNKS, TNKS2, TRPV1 | 2.10561 |
[BP] GO:0040013 | None | ADORA1, ADORA3, APEX1, BCL2, CYP19A1, CYP1B1, DRD2 | 2.10561 |
[BP] GO:0006706 | steroid catabolic process | CYP19A1, CYP1A2, CYP3A4 | 2.10561 |
[BP] GO:1904353 | regulation of telomere capping | AURKB, TNKS, TNKS2 | 2.10561 |
[BP] GO:0006950 | response to stress | ACHE, ADORA1, ADORA3, AKR1B1, ALOX15, APEX1, AXL, BCL2, CA2, CA9, CYP1A1, CYP1A2, CYP1B1, DRD1, DRD2, HSD11B2, MMP2, MMP9, PPARA, PTPN1, SRC, TOP2A, TRPV1 | 2.06731 |
[BP] GO:0080090 | regulation of primary metabolic process | ADORA1, ADORA3, ALOX15, APEX1, AURKB, BCL2, CA9, CDC25B, CSNK2A1, CYP1A1, CYP1B1, DRD1, DRD2, ESR1, ESR2, ESRRA, ESRRB, F3, FABP3, FABP4, FLT3, GLO1, IGF1R, KDR, MET, MMP12, MMP9, NR3C1, PIM1, PPARA, PTPN1, SRC, TNKS, TNKS2, TOP2A, TRPV1, XDH | 2.0672 |
[BP] GO:0006082 | organic acid metabolic process | ALOX12, ALOX15, ALOX5, CYP1A1, CYP1A2, CYP1B1, FABP3, GBA2, GLO1, PIM1, PPARA, TYR | 2.0672 |
[BP] GO:1904357 | None | SRC, TNKS, TNKS2 | 2.0672 |
[BP] GO:0010648 | negative regulation of cell communication | ACHE, ADORA1, BCL2, DRD1, DRD2, ESR1, ESR2, IGF1R, MET, MMP12, MMP9, PTPN1, SRC, XDH | 2.0672 |
[BP] GO:0023057 | negative regulation of signaling | ACHE, ADORA1, BCL2, DRD1, DRD2, ESR1, ESR2, IGF1R, MET, MMP12, MMP9, PTPN1, SRC, XDH | 2.06098 |
[BP] GO:0071495 | cellular response to endogenous stimulus | AKR1B1, APEX1, DRD1, ESR1, FLT3, IGF1R, MMP2, NR3C1, SRC, TRPV1 | 2.06098 |
[BP] GO:0021853 | None | DRD1, DRD2 | 2.06098 |
[BP] GO:0043696 | None | CDK6, ESRRB | 2.06098 |
[BP] GO:0043697 | None | CDK6, ESRRB | 2.06098 |
[BP] GO:0010641 | None | F3, SRC | 2.06098 |
[BP] GO:0007598 | None | F10, F3 | 2.06098 |
[BP] GO:1904936 | None | DRD1, DRD2 | 2.06098 |
[BP] GO:0051122 | hepoxilin biosynthetic process | ALOX12, ALOX15 | 2.06098 |
[BP] GO:0051121 | hepoxilin metabolic process | ALOX12, ALOX15 | 2.06098 |
[BP] GO:0042321 | None | ADORA1, DRD2 | 2.06098 |
[BP] GO:0044243 | multicellular organismal catabolic process | MMP1, MMP12, MMP2, MMP9 | 2.05348 |
[BP] GO:0009991 | response to extracellular stimulus | ALPL, AXL, BCL2, CYP1A1, HSD11B2, SRC, TRPV1, TYR | 2.05341 |
[BP] GO:0051384 | response to glucocorticoid | ALPL, BCL2, FLT3, HSD11B2, NR3C1 | 2.05281 |
[BP] GO:0008209 | androgen metabolic process | CYP19A1, CYP3A4, ESR1 | 2.0485 |
[BP] GO:0043412 | macromolecule modification | ALPI, ALPL, APEX1, AURKB, AXL, BCL2, CDC25B, CDK6, CSNK2A1, DRD1, ESR1, F10, FLT3, FUT7, IGF1R, KDR, MET, NR3C1, PIM1, PTPN1, SRC, TNKS, TNKS2, TOP1, TOP2A | 2.01266 |
[BP] GO:0042327 | positive regulation of phosphorylation | ADORA1, ALOX15, BCL2, CDC25B, DRD2, ESRRB, FLT3, KDR, MMP9, PTPN1, SRC, XDH | 2.00059 |
[CC] GO:0044444 | cytoplasmic part | ACHE, ADORA1, AKR1B1, AKR1B10, ALOX12, ALOX15, ALOX5, AOX1, APEX1, AURKB, BCL2, CA1, CA2, CA4, CA7, CDC25B, CDK6, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, DRD1, DRD2, ESR1, ESR2, F10, FABP3, FABP4, FLT3, FUT7, GBA2, GLO1, HSD11B1, HSD11B2, HSD17B1, HSD17B2, KDR, MMP2, MMP9, NR3C1, PIM1, PTPN1, SRC, TNKS, TNKS2, TOP1, TOP2A, TRPV1, TYR, XDH | 3.47838 |
[CC] GO:0009330 | None | TOP1, TOP2A | 2.81354 |
[CC] GO:0016020 | membrane | ACHE, ADORA1, ADORA3, ALOX12, ALOX15, ALOX5, ALPI, ALPL, AXL, BCL2, CA12, CA14, CA2, CA4, CA9, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, DRD1, DRD2, ESR1, F10, F3, FLT3, FUT7, GBA2, GLO1, HSD11B1, HSD11B2, HSD17B2, IGF1R, KDR, MET, MMP2, PIM1, PTPN1, SRC, TNKS, TNKS2, TRPV1, TYR | 2.49864 |
[CC] GO:0031233 | None | CA4, F10, F3 | 2.36507 |
[CC] GO:0005886 | plasma membrane | ACHE, ADORA1, ADORA3, ALOX12, ALOX15, ALPI, ALPL, AXL, CA12, CA14, CA2, CA4, CA9, CSNK2A1, DRD1, DRD2, ESR1, F10, F3, FLT3, GBA2, GLO1, IGF1R, KDR, MET, MMP2, PIM1, PTPN1, SRC, TRPV1 | 2.10561 |
[CC] GO:0031253 | None | ADORA1, CA4, CA9, DRD1, DRD2, SRC, TRPV1 | 2.0672 |
[CC] GO:0043227 | membrane-bounded organelle | ACHE, ADORA1, AKR1B1, AKR1B10, ALOX12, ALPL, AOX1, APEX1, AURKB, AXL, BCL2, CA1, CA2, CA4, CDK6, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, DRD1, DRD2, ESR1, ESR2, ESRRA, ESRRB, F3, FABP3, FABP4, FLT3, FUT7, GBA2, GLO1, IGF1R, KDR, MMP12, MMP2, MMP9, NR3C1, PIM1, PPARA, PTPN1, SRC, TNKS, TNKS2, TOP1, TOP2A, TYR, XDH | 2.06098 |
[CC] GO:0044432 | endoplasmic reticulum part | BCL2, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, DRD1, F10, FLT3, GBA2, HSD11B1, HSD11B2, HSD17B2, PTPN1 | 2.06098 |
[MF] GO:0046914 | transition metal ion binding | ALOX12, ALOX15, ALOX5, ALPI, AOX1, CA1, CA12, CA2, CA4, CA7, CA9, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, ESR1, ESR2, ESRRA, ESRRB, GLO1, MMP1, MMP12, MMP2, MMP9, NR3C1, PIM1, PPARA, PTPN1, TNKS, TYR, XDH | 17.7382 |
[MF] GO:0043167 | ion binding | ACHE, ALOX12, ALOX15, ALOX5, ALPI, ALPL, AOX1, APEX1, AURKB, AXL, CA1, CA12, CA14, CA2, CA4, CA7, CA9, CDK6, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, DRD1, DRD2, ESR1, ESR2, ESRRA, ESRRB, F10, F3, FABP3, FABP4, FLT3, GLO1, HSD17B1, IGF1R, KDR, MET, MMP1, MMP12, MMP2, MMP9, NR3C1, PIM1, PPARA, PTPN1, SRC, TNKS, TNKS2, TOP1, TOP2A, TRPV1, TYR, XDH | 13.5767 |
[MF] GO:0003824 | catalytic activity | ACHE, ADORA1, AKR1B1, AKR1B10, ALOX12, ALOX15, ALOX5, ALPI, ALPL, AOX1, APEX1, AURKB, AXL, CA1, CA12, CA14, CA2, CA4, CA7, CA9, CDC25B, CDK6, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, F10, F3, FLT3, FUT7, GBA2, GLO1, HSD11B1, HSD11B2, HSD17B1, HSD17B2, IGF1R, KDR, MET, MMP1, MMP12, MMP2, MMP9, PIM1, PTPN1, SRC, TNKS, TNKS2, TOP1, TOP2A, TYR, XDH | 12.6391 |
[MF] GO:0004089 | carbonate dehydratase activity | CA1, CA12, CA14, CA2, CA4, CA7, CA9 | 10.0003 |
[MF] GO:0043169 | cation binding | ACHE, ALOX12, ALOX15, ALOX5, ALPI, ALPL, AOX1, APEX1, AURKB, CA1, CA12, CA14, CA2, CA4, CA7, CA9, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, DRD1, DRD2, ESR1, ESR2, ESRRA, ESRRB, F10, GLO1, MMP1, MMP12, MMP2, MMP9, NR3C1, PIM1, PPARA, PTPN1, TNKS, TNKS2, TOP2A, TRPV1, TYR, XDH | 9.55615 |
[MF] GO:0008270 | zinc ion binding | ALPI, CA1, CA12, CA2, CA4, CA7, CA9, ESR1, ESR2, ESRRA, ESRRB, GLO1, MMP1, MMP12, MMP2, MMP9, NR3C1, PPARA, PTPN1, TNKS | 8.37409 |
[MF] GO:0046872 | metal ion binding | ALOX12, ALOX15, ALOX5, ALPI, ALPL, AOX1, APEX1, AURKB, CA1, CA12, CA14, CA2, CA4, CA7, CA9, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, ESR1, ESR2, ESRRA, ESRRB, F10, GLO1, MMP1, MMP12, MMP2, MMP9, NR3C1, PIM1, PPARA, PTPN1, TNKS, TNKS2, TOP2A, TRPV1, TYR, XDH | 7.93092 |
[MF] GO:0016491 | oxidoreductase activity | AKR1B1, AKR1B10, ALOX12, ALOX15, ALOX5, AOX1, APEX1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, HSD11B1, HSD11B2, HSD17B1, HSD17B2, TYR, XDH | 7.46384 |
[MF] GO:0005506 | iron ion binding | ALOX12, ALOX15, ALOX5, AOX1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, XDH | 6.82663 |
[MF] GO:0016835 | carbon-oxygen lyase activity | APEX1, CA1, CA12, CA14, CA2, CA4, CA7, CA9 | 6.82663 |
[MF] GO:0005496 | steroid binding | CYP3A4, ESR1, ESR2, ESRRA, ESRRB, HSD11B2, HSD17B1, NR3C1 | 6.46444 |
[MF] GO:0016836 | hydro-lyase activity | CA1, CA12, CA14, CA2, CA4, CA7, CA9 | 6.3617 |
[MF] GO:0008289 | lipid binding | ALOX15, AXL, CYP3A4, ESR1, ESR2, ESRRA, ESRRB, F10, F3, FABP3, FABP4, HSD11B2, HSD17B1, NR3C1, PPARA, TRPV1 | 6.2997 |
[MF] GO:0070330 | aromatase activity | CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4 | 5.2695 |
[MF] GO:0016829 | lyase activity | APEX1, CA1, CA12, CA14, CA2, CA4, CA7, CA9, GLO1 | 5.2684 |
[MF] GO:0016614 | oxidoreductase activity, acting on CH-OH group of donors | AKR1B1, AKR1B10, AOX1, HSD11B1, HSD11B2, HSD17B1, HSD17B2, XDH | 5.09378 |
[MF] GO:0016712 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen | CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4 | 5.02607 |
[MF] GO:0008144 | drug binding | ACHE, AURKB, AXL, CDK6, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, DRD1, DRD2, FLT3, IGF1R, KDR, MET, PIM1, PPARA, SRC, TOP1, TOP2A, TRPV1 | 4.87494 |
[MF] GO:0003707 | steroid hormone receptor activity | ESR1, ESR2, ESRRA, ESRRB, NR3C1, PPARA | 4.77448 |
[MF] GO:0019825 | oxygen binding | CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4 | 3.95536 |
[MF] GO:0098531 | transcription factor activity, direct ligand regulated sequence-specific DNA binding | ESR1, ESR2, ESRRA, ESRRB, PPARA | 3.80251 |
[MF] GO:0004879 | nuclear receptor activity | ESR1, ESR2, ESRRA, ESRRB, PPARA | 3.80251 |
[MF] GO:0004497 | monooxygenase activity | CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, TYR | 3.70347 |
[MF] GO:0033764 | steroid dehydrogenase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor | HSD11B1, HSD11B2, HSD17B1, HSD17B2 | 3.41258 |
[MF] GO:0004714 | transmembrane receptor protein tyrosine kinase activity | AXL, FLT3, IGF1R, KDR, MET | 3.37955 |
[MF] GO:0016229 | steroid dehydrogenase activity | HSD11B1, HSD11B2, HSD17B1, HSD17B2 | 3.30412 |
[MF] GO:0038023 | signaling receptor activity | ADORA1, ADORA3, AXL, DRD1, DRD2, ESR1, ESR2, ESRRA, ESRRB, F3, FLT3, IGF1R, KDR, MET, NR3C1, PPARA, TRPV1 | 3.27824 |
[MF] GO:0016725 | oxidoreductase activity, acting on CH or CH2 groups | CYP1A2, CYP3A4, XDH | 3.26397 |
[MF] GO:0016616 | oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor | AKR1B1, AKR1B10, HSD11B1, HSD11B2, HSD17B1, HSD17B2 | 3.23724 |
[MF] GO:0020037 | heme binding | CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, SRC | 3.08231 |
[MF] GO:0060089 | molecular transducer activity | ADORA1, ADORA3, AXL, CDK6, DRD1, DRD2, ESR1, ESR2, ESRRA, ESRRB, F3, FLT3, IGF1R, KDR, MET, NR3C1, PPARA, TRPV1 | 3.05162 |
[MF] GO:0048037 | cofactor binding | AOX1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, HSD11B2, HSD17B1, SRC, XDH | 3.04473 |
[MF] GO:0044877 | macromolecular complex binding | ACHE, ADORA1, APEX1, CSNK2A1, ESRRB, FLT3, IGF1R, KDR, MMP12, MMP9, PIM1, PPARA, PTPN1, SRC | 3.04473 |
[MF] GO:0019199 | transmembrane receptor protein kinase activity | AXL, FLT3, IGF1R, KDR, MET | 2.94401 |
[MF] GO:0046906 | tetrapyrrole binding | CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, SRC | 2.9323 |
[MF] GO:0038052 | RNA polymerase II transcription factor activity, estrogen-activated sequence-specific DNA binding | ESR1, ESR2 | 2.81354 |
[MF] GO:0003845 | None | HSD11B1, HSD11B2 | 2.81354 |
[MF] GO:0047977 | hepoxilin-epoxide hydrolase activity | ALOX12, ALOX15 | 2.81354 |
[MF] GO:0004672 | protein kinase activity | AURKB, AXL, CDK6, CSNK2A1, FLT3, IGF1R, KDR, MET, PIM1, SRC, TOP1 | 2.75095 |
[MF] GO:0004872 | receptor activity | ADORA1, ADORA3, AXL, DRD1, DRD2, ESR1, ESR2, ESRRA, ESRRB, F3, FLT3, IGF1R, KDR, MET, NR3C1, PPARA, TRPV1 | 2.71187 |
[MF] GO:0016705 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen | CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, TYR | 2.71187 |
[MF] GO:0016903 | None | AKR1B1, AKR1B10, AOX1, XDH | 2.71187 |
[MF] GO:0032403 | protein complex binding | ACHE, ADORA1, APEX1, ESRRB, FLT3, IGF1R, KDR, MMP12, MMP9, PPARA, PTPN1, SRC | 2.71187 |
[MF] GO:0001047 | None | ESR1, ESR2, ESRRB, MMP12, NR3C1, TOP1 | 2.54604 |
[MF] GO:0070576 | vitamin D 24-hydroxylase activity | CYP1A1, CYP3A4 | 2.43499 |
[MF] GO:0004052 | arachidonate 12-lipoxygenase activity | ALOX12, ALOX15 | 2.43499 |
[MF] GO:0051120 | hepoxilin A3 synthase activity | ALOX12, ALOX15 | 2.43499 |
[MF] GO:0009055 | electron transfer activity | AKR1B1, AOX1, CYP19A1, CYP1A2, XDH | 2.42821 |
[MF] GO:0004713 | protein tyrosine kinase activity | AXL, FLT3, IGF1R, KDR, MET, SRC | 2.40665 |
[MF] GO:0017171 | serine hydrolase activity | ACHE, F10, F3, MMP1, MMP12, MMP2, MMP9 | 2.2817 |
[MF] GO:0004871 | signal transducer activity | ADORA1, ADORA3, AXL, DRD1, DRD2, ESR1, ESR2, ESRRA, ESRRB, F3, FLT3, IGF1R, KDR, MET, NR3C1, PPARA, TRPV1 | 2.27977 |
[MF] GO:0034056 | estrogen response element binding | ESR1, ESR2 | 2.20997 |
[MF] GO:0034875 | caffeine oxidase activity | CYP1A2, CYP3A4 | 2.20997 |
[MF] GO:0033695 | oxidoreductase activity, acting on CH or CH2 groups, quinone or similar compound as acceptor | CYP1A2, CYP3A4 | 2.20997 |
[MF] GO:0016773 | phosphotransferase activity, alcohol group as acceptor | AURKB, AXL, CDK6, CSNK2A1, FLT3, IGF1R, KDR, MET, PIM1, SRC, TOP1 | 2.1922 |
[MF] GO:0016702 | oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen | ALOX12, ALOX15, ALOX5 | 2.10561 |
[MF] GO:0042802 | identical protein binding | ACHE, AOX1, BCL2, CSNK2A1, DRD2, ESR1, ESR2, FLT3, IGF1R, KDR, MET, MMP9, TOP2A, TRPV1, TYR, XDH | 2.0672 |
[MF] GO:0016701 | oxidoreductase activity, acting on single donors with incorporation of molecular oxygen | ALOX12, ALOX15, ALOX5 | 2.0672 |
[MF] GO:0101020 | estrogen 16-alpha-hydroxylase activity | CYP1A1, CYP3A4 | 2.06098 |
[MF] GO:0030284 | estrogen receptor activity | ESR1, ESR2 | 2.06098 |
KEGG Pathway ID | Enriched Genes | Log10 Adjusted P-value |
---|---|---|
Steroid hormone biosynthesis_Homo sapiens_hsa00140 | HSD11B1, HSD11B2, HSD17B1, HSD17B2, CYP1A2, CYP1A1, CYP1B1, CYP3A4, CYP19A1 | 10.7104 |
Nitrogen metabolism_Homo sapiens_hsa00910 | CA12, CA1, CA2, CA4, CA7, CA9, CA14 | 11.0508 |
Ovarian steroidogenesis_Homo sapiens_hsa04913 | ALOX5, HSD17B1, HSD17B2, CYP1A1, CYP1B1, CYP19A1, IGF1R | 7.8551 |
Metabolic pathways_Homo sapiens_hsa01100 | ALOX15, AKR1B1, ALOX12, TYR, CYP3A4, GBA2, CYP19A1, HSD11B1, FUT7, AKR1B10, ALOX5, HSD17B1, HSD17B2, CYP1A2, CYP1A1, AOX1, ALPL, ALPI, XDH | 6.3322 |
Proteoglycans in cancer_Homo sapiens_hsa05205 | SRC, MMP2, KDR, MMP9, MET, ESR1, IGF1R | 3.9927 |
Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | HSD11B1, CYP1A2, CYP1A1, CYP1B1, CYP3A4 | 3.9927 |
Adherens junction_Homo sapiens_hsa04520 | PTPN1, CSNK2A1, SRC, MET, IGF1R | 3.9927 |
Tryptophan metabolism_Homo sapiens_hsa00380 | CYP1A2, CYP1A1, AOX1, CYP1B1 | 3.8374 |
Pathways in cancer_Homo sapiens_hsa05200 | CDK6, FLT3, MMP1, MMP2, BCL2, MMP9, MET, IGF1R | 3.2208 |
Estrogen signaling pathway_Homo sapiens_hsa04915 | SRC, MMP2, MMP9, ESR1, ESR2 | 3.5965 |
Chemical carcinogenesis_Homo sapiens_hsa05204 | HSD11B1, CYP1A2, CYP1A1, CYP1B1, CYP3A4 | 3.8576 |
Bladder cancer_Homo sapiens_hsa05219 | SRC, MMP1, MMP2, MMP9 | 3.8374 |
MicroRNAs in cancer_Homo sapiens_hsa05206 | CDK6, BCL2, PIM1, CYP1B1, MMP9, MET, CDC25B | 3.1974 |
Retinol metabolism_Homo sapiens_hsa00830 | CYP1A2, CYP1A1, AOX1, CYP3A4 | 3.1848 |
AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | MMP2, BCL2, PIM1, F3 | 2.5763 |
Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | ADORA3, ADORA1, TRPV1, DRD1, NR3C1, DRD2 | 2.6017 |
PPAR signaling pathway_Homo sapiens_hsa03320 | FABP3, FABP4, MMP1, PPARA | 3.113 |
Focal adhesion_Homo sapiens_hsa04510 | SRC, KDR, BCL2, MET, IGF1R | 2.3999 |
Rap1 signaling pathway_Homo sapiens_hsa04015 | SRC, KDR, DRD2, MET, IGF1R | 2.3355 |
Hepatitis B_Homo sapiens_hsa05161 | CDK6, SRC, BCL2, MMP9 | 2.0785 |
Arachidonic acid metabolism_Homo sapiens_hsa00590 | ALOX5, ALOX15, ALOX12 | 2.1532 |
Melanoma_Homo sapiens_hsa05218 | CDK6, MET, IGF1R | 2.0364 |
Prolactin signaling pathway_Homo sapiens_hsa04917 | SRC, ESR1, ESR2 | 2.0353 |
Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | CYP1A2, AOX1, CYP3A4 | 2.055 |
Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | FLT3, MMP9, MET, IGF1R | 1.8327 |
cAMP signaling pathway_Homo sapiens_hsa04024 | ADORA1, DRD1, DRD2, PPARA | 1.7261 |
Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | SRC, ALOX12, TRPV1 | 1.7261 |
Linoleic acid metabolism_Homo sapiens_hsa00591 | ALOX15, CYP1A2, CYP3A4 | 3.0025 |
PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | CDK6, KDR, BCL2, MET, IGF1R | 1.6517 |
Gap junction_Homo sapiens_hsa04540 | SRC, DRD1, DRD2 | 1.8327 |
Serotonergic synapse_Homo sapiens_hsa04726 | ALOX5, ALOX15, ALOX12 | 1.6321 |
Endocytosis_Homo sapiens_hsa04144 | SRC, KDR, MET, IGF1R | 1.4295 |
Sphingolipid signaling pathway_Homo sapiens_hsa04071 | ADORA3, BCL2, ADORA1 | 1.5715 |
Jak-STAT signaling pathway_Homo sapiens_hsa04630 | BCL2, PIM1, AOX1 | 1.3117 |
Ras signaling pathway_Homo sapiens_hsa04014 | KDR, MET, IGF1R | 1.0322 |
Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | FABP4, ADORA1 | 1.3162 |
Acute myeloid leukemia_Homo sapiens_hsa05221 | FLT3, PIM1 | 1.3117 |
Glioma_Homo sapiens_hsa05214 | CDK6, IGF1R | 1.2507 |
Prostate cancer_Homo sapiens_hsa05215 | BCL2, IGF1R | 1.0562 |
VEGF signaling pathway_Homo sapiens_hsa04370 | SRC, KDR | 1.2846 |
GnRH signaling pathway_Homo sapiens_hsa04912 | SRC, MMP2 | 1.0538 |
Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | FLT3, KDR, MET | 0.9274 |
Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | CDC25B, IGF1R | 1.0175 |
Central carbon metabolism in cancer_Homo sapiens_hsa05230 | FLT3, MET | 1.2349 |
Cholinergic synapse_Homo sapiens_hsa04725 | ACHE, BCL2 | 0.9416 |
Small cell lung cancer_Homo sapiens_hsa05222 | CDK6, BCL2 | 1.0755 |
Morphine addiction_Homo sapiens_hsa05032 | ADORA1, DRD1 | 1.0538 |
Insulin resistance_Homo sapiens_hsa04931 | PTPN1, PPARA | 0.9488 |
HIF-1 signaling pathway_Homo sapiens_hsa04066 | BCL2, IGF1R | 0.9859 |
Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | SRC, MET | 1.1374 |
Glycerolipid metabolism_Homo sapiens_hsa00561 | AKR1B10, AKR1B1 | 1.3025 |
Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | SRC, MET | 1.2314 |
NF-kappa B signaling pathway_Homo sapiens_hsa04064 | CSNK2A1, BCL2 | 1.0441 |
Complement and coagulation cascades_Homo sapiens_hsa04610 | F10, F3 | 1.1353 |
Bile secretion_Homo sapiens_hsa04976 | CA2, CYP3A4 | 1.2049 |
Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | SRC, ESR1 | 0.9274 |
Measles_Homo sapiens_hsa05162 | CDK6, CSNK2A1 | 0.8383 |
Toxoplasmosis_Homo sapiens_hsa05145 | ALOX5, BCL2 | 0.9274 |
Leukocyte transendothelial migration_Homo sapiens_hsa04670 | MMP2, MMP9 | 0.9274 |
Dopaminergic synapse_Homo sapiens_hsa04728 | DRD1, DRD2 | 0.8719 |
Parkinson's disease_Homo sapiens_hsa05012 | DRD1, DRD2 | 0.8239 |
Cell cycle_Homo sapiens_hsa04110 | CDK6, CDC25B | 0.8959 |
Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | ESRRB, IGF1R | 0.8239 |
Tight junction_Homo sapiens_hsa04530 | CSNK2A1, SRC | 0.828 |
Cocaine addiction_Homo sapiens_hsa05030 | DRD1, DRD2 | 1.4166 |
cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | ADORA3, ADORA1 | 0.7387 |
Alcoholism_Homo sapiens_hsa05034 | DRD1, DRD2 | 0.6996 |
Tuberculosis_Homo sapiens_hsa05152 | SRC, BCL2 | 0.6996 |
Epstein-Barr virus infection_Homo sapiens_hsa05169 | CSNK2A1, BCL2 | 0.6411 |
Drug metabolism - other enzymes_Homo sapiens_hsa00983 | CYP3A4, XDH | 1.4481 |
Viral carcinogenesis_Homo sapiens_hsa05203 | CDK6, SRC | 0.6411 |
MAPK signaling pathway_Homo sapiens_hsa04010 | CDC25B | 0.2386 |
Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | SRC | 0.2857 |
Purine metabolism_Homo sapiens_hsa00230 | XDH | 0.3331 |
Herpes simplex infection_Homo sapiens_hsa05168 | CSNK2A1 | 0.3239 |
Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | BCL2 | 0.3428 |
Calcium signaling pathway_Homo sapiens_hsa04020 | DRD1 | 0.3292 |
Chemokine signaling pathway_Homo sapiens_hsa04062 | SRC | 0.3237 |
Apoptosis_Homo sapiens_hsa04210 | BCL2 | 0.3886 |
Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | BCL2 | 0.3766 |
Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | PPARA | 0.3732 |
Galactose metabolism_Homo sapiens_hsa00052 | AKR1B10, AKR1B1 | 1.7261 |
Oxytocin signaling pathway_Homo sapiens_hsa04921 | SRC | 0.3615 |
Insulin signaling pathway_Homo sapiens_hsa04910 | PTPN1 | 0.3886 |
Wnt signaling pathway_Homo sapiens_hsa04310 | CSNK2A1 | 0.3872 |
FoxO signaling pathway_Homo sapiens_hsa04068 | IGF1R | 0.3992 |
Platelet activation_Homo sapiens_hsa04611 | SRC | 0.413 |
Hepatitis C_Homo sapiens_hsa05160 | PPARA | 0.3992 |
Neurotrophin signaling pathway_Homo sapiens_hsa04722 | BCL2 | 0.4136 |
Oocyte meiosis_Homo sapiens_hsa04114 | IGF1R | 0.413 |
AMPK signaling pathway_Homo sapiens_hsa04152 | IGF1R | 0.413 |
Axon guidance_Homo sapiens_hsa04360 | MET | 0.4083 |
TNF signaling pathway_Homo sapiens_hsa04668 | MMP9 | 0.4411 |
Tyrosine metabolism_Homo sapiens_hsa00350 | AOX1, TYR | 1.6325 |
Melanogenesis_Homo sapiens_hsa04916 | TYR | 0.4683 |
Glucagon signaling pathway_Homo sapiens_hsa04922 | PPARA | 0.4683 |
Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | IGF1R | 0.4794 |
ErbB signaling pathway_Homo sapiens_hsa04012 | SRC | 0.4921 |
Glycerophospholipid metabolism_Homo sapiens_hsa00564 | ACHE | 0.4794 |
Pancreatic secretion_Homo sapiens_hsa04972 | CA2 | 0.4794 |
Rheumatoid arthritis_Homo sapiens_hsa05323 | MMP1 | 0.4917 |
Hematopoietic cell lineage_Homo sapiens_hsa04640 | FLT3 | 0.4921 |
GABAergic synapse_Homo sapiens_hsa04727 | SRC | 0.4921 |
Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | CSNK2A1 | 0.4919 |
Peroxisome_Homo sapiens_hsa04146 | XDH | 0.5021 |
Chronic myeloid leukemia_Homo sapiens_hsa05220 | CDK6 | 0.5426 |
Fructose and mannose metabolism_Homo sapiens_hsa00051 | AKR1B10, AKR1B1 | 1.6838 |
Gastric acid secretion_Homo sapiens_hsa04971 | CA2 | 0.5415 |
Adipocytokine signaling pathway_Homo sapiens_hsa04920 | PPARA | 0.5546 |
Pancreatic cancer_Homo sapiens_hsa05212 | CDK6 | 0.5645 |
Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | IGF1R | 0.5645 |
Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | CA2, CA4 | 1.8834 |
Renal cell carcinoma_Homo sapiens_hsa05211 | MET | 0.5645 |
Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | AKR1B10, AKR1B1 | 1.6321 |
Amphetamine addiction_Homo sapiens_hsa05031 | DRD1 | 0.563 |
p53 signaling pathway_Homo sapiens_hsa04115 | CDK6 | 0.556 |
Long-term depression_Homo sapiens_hsa04730 | IGF1R | 0.575 |
Renin secretion_Homo sapiens_hsa04924 | ADORA1 | 0.5645 |
Colorectal cancer_Homo sapiens_hsa05210 | BCL2 | 0.5667 |
Shigellosis_Homo sapiens_hsa05131 | SRC | 0.5645 |
Non-small cell lung cancer_Homo sapiens_hsa05223 | CDK6 | 0.5974 |
Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | BCL2 | 0.6299 |
Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | ESR1 | 0.6411 |
Malaria_Homo sapiens_hsa05144 | MET | 0.6411 |
Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | AOX1 | 0.6411 |
Sphingolipid metabolism_Homo sapiens_hsa00600 | GBA2 | 0.6411 |
Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | HSD11B2 | 0.6985 |
Pyruvate metabolism_Homo sapiens_hsa00620 | GLO1 | 0.6934 |
Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | FUT7 | 0.7657 |
Base excision repair_Homo sapiens_hsa03410 | APEX1 | 0.7457 |
Folate biosynthesis_Homo sapiens_hsa00790 | ALPL, ALPI | 2.2144 |
Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | AOX1 | 0.7878 |
Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | FUT7 | 0.8219 |
Collecting duct acid secretion_Homo sapiens_hsa04966 | CA2 | 0.8119 |
Other glycan degradation_Homo sapiens_hsa00511 | GBA2 | 0.9274 |
Caffeine metabolism_Homo sapiens_hsa00232 | CYP1A2, XDH | 3.0266 |
Vitamin B6 metabolism_Homo sapiens_hsa00750 | AOX1 | 1.2507 |